| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/04/2011 | EP2316825A1 Pyridyl derivatives and their use as therapeutic agents |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315751A1 Alkynyl alcohols as kinase inhibitors |
| 05/04/2011 | EP2315750A1 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP2315521A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h 4 receptor |
| 05/04/2011 | EP1716117B1 Ionic uv-a sunscreens and compositions containing them |
| 05/04/2011 | EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/04/2011 | CN1875000B Method for producing bactericidal pyridine compound and bactericidal pyridine compound |
| 05/04/2011 | CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor |
| 05/04/2011 | CN102046600A New crystalline pyrithione/zinc oxide complex and physiologic/antibiotic active composite containing the same |
| 05/04/2011 | CN102046599A Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
| 05/04/2011 | CN102046595A Substituted 4-aminocyclohexane derivatives |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN102040589A Condensed-cyclic compound and organic light emitting diode |
| 05/04/2011 | CN102040555A Synthesis process of organic synthesis intermediate |
| 05/04/2011 | CN102040554A Method for preparing 2-chloro-5-nitropyridine |
| 05/04/2011 | CN102040553A Preparation method of gasoline extraction and desulfurization agent |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102039119A Preparation method of catalyst for combining pyridine |
| 05/04/2011 | CN101597256B Preparation method of paraquat derivatives |
| 05/04/2011 | CN101555253B Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof |
| 05/04/2011 | CN101475581B Terpyridyl complex two-photon material with cell development and preparation |
| 05/04/2011 | CN101392007B Anti-tumor manganese complexes using mitochondria as target point and preparation and use thereof |
| 05/04/2011 | CN101155782B Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 05/03/2011 | US7935852 Fluoridation method |
| 05/03/2011 | US7935848 Butone derivatives useful as cooling agents |
| 05/03/2011 | US7935832 Pyrrole and isoindole carboxamide derivatives as P2X7 modulators |
| 05/03/2011 | US7935826 Insecticidal N-substituted (heteroaryl)cycloalkyl sulfoximines |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935715 Compounds which modulate the CB2 receptor |
| 05/03/2011 | US7935698 Heteroaryl-hydrazone compounds |
| 05/03/2011 | CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain |
| 05/03/2011 | CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 04/28/2011 | WO2011049241A1 Organic electroluminescent element |
| 04/28/2011 | WO2011049027A1 Photoelectric conversion device wherein dye consisting of binuclear ruthenium complex having substituted bipyridyl groups is used, and photochemical cell |
| 04/28/2011 | WO2011048004A1 Inhibitors of the microsomal prostaglandin e2 synthase-1 |
| 04/28/2011 | WO2011023791A3 Method for producing organoaluminium compounds and use thereof |
| 04/28/2011 | WO2011004393A4 Para amino benzoic acid based nanotubes |
| 04/28/2011 | WO2010086454A9 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
| 04/28/2011 | US20110098477 Method Of Producing Compound Having Anti-Hcv Activity |
| 04/28/2011 | US20110098476 Process for preparing bis(thiohydrazide amides) |
| 04/28/2011 | US20110098431 Catalyst Compounds and Use Thereof |
| 04/28/2011 | US20110098430 Catalyst Compounds and Use Thereof |
| 04/28/2011 | US20110098429 Catalyst Compounds and Use Thereof |
| 04/28/2011 | US20110098427 Catalyst Compounds And Use Thereof |
| 04/28/2011 | US20110098353 Compounds for Imaging and Therapy |
| 04/28/2011 | US20110098325 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/28/2011 | US20110098313 Positive allosteric modulators (pam) |
| 04/28/2011 | US20110098298 New Pyridin-3-Amine Derivatives |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098277 Fab I Inhibitors |
| 04/28/2011 | US20110098273 Oligomer-Calcium Channel Blocker Conjugates |
| 04/28/2011 | US20110097718 Ms-compatible nonionic or zwitterionic surfactants in free-flow electrophoresis |
| 04/28/2011 | US20110097347 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |
| 04/28/2011 | DE102009049790A1 Preparing 6-chloro-2-trichloro-methyl pyridine comprises using gaseous chlorine and 2-methylpyridine as raw material, introducing excess gaseous chlorine, reacting gaseous chlorine with initiator to form hydrogen chloride gas and purifying |
| 04/27/2011 | EP2315303A1 Dye-sensitized photovoltaic device |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314577A1 Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| 04/27/2011 | EP2314576A1 Phenyl derivatives as PPAR agonists |
| 04/27/2011 | EP2314571A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 04/27/2011 | EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 04/27/2011 | EP2313372A1 Aminopyridine kinase inhibitors |
| 04/27/2011 | EP2313096A1 New compounds v |
| 04/27/2011 | EP2313094A1 New pyridine derivatives as leptin receptor modulator mimetics |
| 04/27/2011 | EP2102199B1 Antibacterial polycyclic urea compounds |
| 04/27/2011 | EP1467967B1 Compounds for modulating cell proliferation |
| 04/27/2011 | EP1177796B1 Medicament for prevention or therapeutic treatment of liver disease |
| 04/27/2011 | CN1810802B 3-substituted-4-pyrimidone derivatives |
| 04/27/2011 | CN102036989A Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036988A Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036987A Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036961A Pyridines and pyrazines as inhibitors of PI3K |
| 04/27/2011 | CN102036960A Substituted pyridin-4-ylmethyl sulfonamides |
| 04/27/2011 | CN102036959A Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036958A Compound comprising phenyl pyridine units |
| 04/27/2011 | CN102036957A Compound comprising phenyl pyridine units |
| 04/27/2011 | CN102036953A Arylsulfonamide-based matrix metalloprotease inhibitors |
| 04/27/2011 | CN102036560A Substituted pyridin-4-ylmethyl sulfonamides |
| 04/27/2011 | CN102030759A Thienopyridine derivative, and preparation method and application thereof |
| 04/27/2011 | CN102030704A 4-(4-aminobenzene-thio)-2-(carbamoymethyl) pyridine derivative as well as preparation method and application thereof |
| 04/27/2011 | CN102030690A Di-sulfoxide ligands with axial chirality and synthesis method thereof |
| 04/27/2011 | CN102030680A Novel oxime ether or ester derivatives with insecticidal activity, preparation method and application thereof |
| 04/27/2011 | CN101219990B Method for distillation of front cut fraction of trichloropyridine sodium alcoholate |
| 04/27/2011 | CN101108821B Method of manufacturing 2-picoline |
| 04/26/2011 | US7932396 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides |
| 04/26/2011 | US7932395 Substituted 1H-dihydropyrazoles, their preparation and use |
| 04/26/2011 | US7932393 Insecticidal (heteroarylalky)alkane thio and oxo amine derivatives |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932275 2-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer's disease |
| 04/26/2011 | US7932272 Antifungal agent containing heterocyclic compound |
| 04/26/2011 | US7932271 Heterocyclic methyl sulfone derivative |
| 04/26/2011 | US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds |
| 04/26/2011 | US7932242 Anticancer agents; radiation and chemical resistance |
| 04/26/2011 | CA2509892C Herbicidally active nicotinoyl derivates |
| 04/26/2011 | CA2492173C Novel 2-pyridylethylbenzamide derivative |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2424565C Novel crystalline forms of a factor xa inhibitor |